Treatment as Prevention¨

New York City’s New HIV Awareness Campaign Shows Intimacy in the Age of HIV

Jasmine Corazon, 37, entered the subway recently and noticed something new. It was an image of a Latino man cozying up to his girlfriend (or wife) from behind, hand on her upper arm and coming in for a nuzzle. Below the intimate image was the encouragement: “Be HIV Sure.” And then the direction: “Be safe, […]

New York City’s New HIV Awareness Campaign Shows Intimacy in the Age of HIV Read More »

Interview: China looks to Canadian province in fight against HIV/AIDS

VANCOUVER, Dec. 18 (Xinhua) — China is looking to Canada’s Pacific coast province of British Columbia (B.C.) for cooperation in the fight against HIV/AIDS, as the latter has become successful and experienced in dealing with spread of the deadly virus and disease. When Chinese authorities said they were looking for new strategies and new ideas

Interview: China looks to Canadian province in fight against HIV/AIDS Read More »

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below